Management of the patient with medically refractory epilepsy
- 1 December 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 9 (12) , 1791-1802
Abstract
Epilepsy imposes a significant clinical, epidemiologic and economic burden on societies throughout the world. Despite the development of more than ten new antiepileptic drugs over the past 15 years...Keywords
This publication has 79 references indexed in Scilit:
- Blood–brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edemaEpilepsia, 2009
- New Developments in Antiepileptic Drug Resistance: An Integrative ViewEpilepsy Currents, 2009
- Antagonism of peripheral inflammation reduces the severity of status epilepticusNeurobiology of Disease, 2009
- The clinical impact of pharmacogenetics on the treatment of epilepsyEpilepsia, 2009
- A role for leukocyte-endothelial adhesion mechanisms in epilepsyNature Medicine, 2008
- SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsyNeuropharmacology, 2008
- Likelihood of seizure remission in an adult population with refractory epilepsyAnnals of Neurology, 2007
- In Vivo and In Vitro Effects of Pilocarpine: Relevance to IctogenesisEpilepsia, 2007
- The Blood–Brain Barrier and EpilepsyEpilepsia, 2006
- Cost of epilepsy in EuropeEuropean Journal of Neurology, 2005